Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)

KCI Citation Count: 0

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes & metabolism journal 2024, 48(5), 205, pp.1005-1007
1. Verfasser:	Lee, Eun Young
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Benzhydryl Compounds - administration & dosage Benzhydryl Compounds - therapeutic use Blood Glucose - analysis Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Drug Therapy, Combination Female Glucosides - administration & dosage Glucosides - therapeutic use Glycated Hemoglobin - analysis Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - therapeutic use Letter Male Metformin - administration & dosage Metformin - therapeutic use Middle Aged Sitagliptin Phosphate - administration & dosage Sitagliptin Phosphate - therapeutic use Sodium-Glucose Transporter 2 Inhibitors - administration & dosage Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Treatment Outcome 내과학
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!